REPL
Price
$4.74
Change
+$0.09 (+1.94%)
Updated
Oct 8, 01:50 PM (EDT)
Capitalization
362.96M
41 days until earnings call
SPRY
Price
$10.64
Change
+$0.32 (+3.10%)
Updated
Oct 8, 01:06 PM (EDT)
Capitalization
1.02B
29 days until earnings call
Interact to see
Advertisement

REPL vs SPRY

Header iconREPL vs SPRY Comparison
Open Charts REPL vs SPRYBanner chart's image
Replimune Group
Price$4.74
Change+$0.09 (+1.94%)
Volume$235
Capitalization362.96M
ARS Pharmaceuticals
Price$10.64
Change+$0.32 (+3.10%)
Volume$418
Capitalization1.02B
REPL vs SPRY Comparison Chart in %
REPL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
REPL vs. SPRY commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REPL is a StrongBuy and SPRY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 08, 2025
Stock price -- (REPL: $4.65 vs. SPRY: $10.33)
Brand notoriety: REPL and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REPL: 56% vs. SPRY: 69%
Market capitalization -- REPL: $362.96M vs. SPRY: $1.02B
REPL [@Biotechnology] is valued at $362.96M. SPRY’s [@Biotechnology] market capitalization is $1.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $105.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REPL’s FA Score shows that 1 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • REPL’s FA Score: 1 green, 4 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, REPL is a better buy in the long-term than SPRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REPL’s TA Score shows that 6 TA indicator(s) are bullish while SPRY’s TA Score has 5 bullish TA indicator(s).

  • REPL’s TA Score: 6 bullish, 2 bearish.
  • SPRY’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, REPL is a better buy in the short-term than SPRY.

Price Growth

REPL (@Biotechnology) experienced а +10.98% price change this week, while SPRY (@Biotechnology) price change was +2.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.26%. For the same industry, the average monthly price growth was +19.20%, and the average quarterly price growth was +87.50%.

Reported Earning Dates

REPL is expected to report earnings on Nov 18, 2025.

SPRY is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+9.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRY($1.02B) has a higher market cap than REPL($363M). SPRY YTD gains are higher at: -2.085 vs. REPL (-61.602). SPRY has higher annual earnings (EBITDA): -59.34M vs. REPL (-268.18M). REPL has more cash in the bank: 403M vs. SPRY (240M). SPRY has less debt than REPL: SPRY (1.66M) vs REPL (76.3M). SPRY has higher revenues than REPL: SPRY (112M) vs REPL (0).
REPLSPRYREPL / SPRY
Capitalization363M1.02B36%
EBITDA-268.18M-59.34M452%
Gain YTD-61.602-2.0852,954%
P/E RatioN/A151.25-
Revenue0112M-
Total Cash403M240M168%
Total Debt76.3M1.66M4,594%
FUNDAMENTALS RATINGS
REPL: Fundamental Ratings
REPL
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
REPLSPRY
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 14 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
REPL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SFES0.900.03
+2.95%
Safeguard Scientifics, Inc.
DBSDF44.561.02
+2.34%
DBS Group Holdings Ltd.
KIKOF8.44N/A
N/A
Kikkoman Corp.
RYHTY7.11N/A
N/A
Ryman Healthcare Ltd.
OZFRY2.65N/A
N/A
OFX Group Limited